Temporary pupil rings useful in complicated MICS

Article

The use of temporary pupil rings for pupil dilation during microincision cataract surgery (MICS) is particularly useful in cases with floppy iris syndrome.

The use of temporary pupil rings for pupil dilation during microincision cataract surgery (MICS) is particularly useful in cases with floppy iris syndrome, according to Boris Malyugin from the S. Fyodorov Eye Microsurgery Complex, Moscow, Russia.

Dr Malyugin and co-workers developed a new temporary pupillary ring that uses the scroll principle of iris margin capture. A total of 59 MICS procedures were carried out in subjects with cataract complicated by glaucoma, pseudoexfoliative syndrome, diabetes and uveitis. Procedures were performed using a 2.2 mm wide incision coaxial MICS. In the control group (32 eyes), conventional iris hooks were used while, in the study group (27 eyes), the temporary pupil expander rings were used.

Intra- and postoperative complications were comparable, with slightly fewer noted in the study group.

The results demonstrated that the temporary pupil ring offered superior endothelial cell protection and decreased hyphemas, fibrinoid reactions and early postoperative hypertension.

The researchers concluded that the use of the temporary pupil ring is a reasonable option for pupil dilation during MICS especially in the cases with floppy iris syndrome.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.